Bibliographic Details
| Title: |
Phase I clinical trial of the bispecific antibody MDX-H210 (anti-Fc?RI × anti-HER-2/neu) in combination with Filgrastim (G-CSF) for treatment of advanced breast cancer. |
| Authors: |
Repp, R.1 Roland.Repp@med3.imed.uni-erlangen.de, van Ojik, H.H.2,3, Valerius, T.1, Groenewegen, G.2, Wieland, G.4, Oetzel, C.1, Stockmeyer, B.1, Becker, W.5, Eisenhut, M.6, Steininger, H.7, Deo, Y.M.8, Blijham, G.H.2, Kalden, J.R.1, van de Winkel, J.G.J.3,9, Gramatzki, M.1 |
| Source: |
British Journal of Cancer. 12/15/2003, Vol. 89 Issue 12, p2234-2243. 10p. |
| Database: |
Academic Search Ultimate |
